Developing an Informant Questionnaire for Cognitive Abilities in Down Syndrome: The Cognitive Scale for Down Syndrome (CS-DS)
- PMID: 27153191
- PMCID: PMC4859552
- DOI: 10.1371/journal.pone.0154596
Developing an Informant Questionnaire for Cognitive Abilities in Down Syndrome: The Cognitive Scale for Down Syndrome (CS-DS)
Abstract
Down syndrome (DS) is the most common genetic cause of intellectual disability (ID). Abilities relating to executive function, memory and language are particularly affected in DS, although there is a large variability across individuals. People with DS also show an increased risk of developing dementia. While assessment batteries have been developed for adults with DS to assess cognitive abilities, these batteries may not be suitable for those with more severe IDs, dementia, or visual / hearing difficulties. Here we report the development of an informant rated questionnaire, the Cognitive Scale for Down Syndrome (CS-DS), which focuses on everyday abilities relating to executive function, memory and language, and is suitable for assessing these abilities in all adults with DS regardless of cognitive ability. Complete questionnaires were collected about 128 individuals with DS. After final question selection we found high internal consistency scores across the total questionnaire and within the executive function, memory and language domains. CS-DS scores showed a wide range, with minimal floor and ceiling effects. We found high interrater (n = 55) and test retest (n = 36) intraclass correlations. CS-DS scores were significantly lower in those aged 41+ with significant cognitive decline compared to those without decline. Across all adults without cognitive decline, CS-DS scores correlated significantly to measures of general abilities. Exploratory factor analysis suggested five factors within the scale, relating to memory, self-regulation / inhibition, self-direction / initiation, communication, and focussing attention. The CS-DS therefore shows good interrater and test retest reliability, and appears to be a valid and suitable informant rating tool for assessing everyday cognitive abilities in a wide range of individuals with DS. Such a questionnaire may be a useful outcome measure for intervention studies to assess improvements to cognition, in addition to detecting dementia-related cognitive decline. The CS-DS may also be a useful tool for other populations with ID.
Conflict of interest statement
Figures


Similar articles
-
Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome.Front Psychiatry. 2019 Apr 16;10:158. doi: 10.3389/fpsyt.2019.00158. eCollection 2019. Front Psychiatry. 2019. PMID: 31057430 Free PMC article.
-
The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome.Wellcome Open Res. 2016 Nov 15;1:11. doi: 10.12688/wellcomeopenres.9961.1. Wellcome Open Res. 2016. PMID: 28018980 Free PMC article.
-
A Multicentre Italian Validation Study in Aging Adults with Down Syndrome and Other Forms of Intellectual Disabilities: Dementia Screening Questionnaire for Individuals with Intellectual Disabilities.Curr Alzheimer Res. 2017;14(7):709-721. doi: 10.2174/1567205014666170117094757. Curr Alzheimer Res. 2017. PMID: 28124590 Clinical Trial.
-
Memory profiles in Down syndrome across development: a review of memory abilities through the lifespan.J Neurodev Disord. 2018 Jan 29;10(1):5. doi: 10.1186/s11689-017-9220-y. J Neurodev Disord. 2018. PMID: 29378508 Free PMC article. Review.
-
Down syndrome: Cognitive and behavioral functioning across the lifespan.Am J Med Genet C Semin Med Genet. 2015 Jun;169(2):135-49. doi: 10.1002/ajmg.c.31439. Epub 2015 May 18. Am J Med Genet C Semin Med Genet. 2015. PMID: 25989505 Review.
Cited by
-
A 12-week exercise programme has a positive effect on everyday executive function in young people with Down syndrome: a pilot non-randomised controlled trial.J Intellect Disabil Res. 2022 Dec;66(12):924-938. doi: 10.1111/jir.12979. Epub 2022 Sep 13. J Intellect Disabil Res. 2022. PMID: 36101998 Free PMC article. Clinical Trial.
-
The importance of understanding individual differences in Down syndrome.F1000Res. 2016 Mar 23;5:F1000 Faculty Rev-389. doi: 10.12688/f1000research.7506.1. eCollection 2016. F1000Res. 2016. PMID: 27019699 Free PMC article. Review.
-
Charting the future: current and future directions in translational research for individuals with Down syndrome.J Neurodev Disord. 2025 Jul 8;17(1):38. doi: 10.1186/s11689-025-09630-8. J Neurodev Disord. 2025. PMID: 40629284 Free PMC article. Review.
-
Individual cognitive stimulation therapy for people with intellectual disability and dementia: protocol of a feasibility randomised controlled trial.BMJ Open. 2018 Dec 9;8(12):e022136. doi: 10.1136/bmjopen-2018-022136. BMJ Open. 2018. PMID: 30530576 Free PMC article. Clinical Trial.
-
The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome.J Alzheimers Dis. 2018;63(2):797-819. doi: 10.3233/JAD-170920. J Alzheimers Dis. 2018. PMID: 29689719 Free PMC article.
References
-
- Startin CM, Hamburg S, Hithersay R, al Janabi T, Strydom A (submitted) LonDownS: assessing cognitive decline and cognitive abilities in people with Down syndrome.
-
- Rowe J, Lavender A, Turk V (2006) Cognitive executive function in Down's syndrome. Br J Clin Psychol 45: 5–17. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical